Acute Promyelocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
651
|
21
|
0.320 |
None |
1.000 |
2 |
|
2002 |
2013 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
5
|
0.310 |
None |
1.000 |
1 |
|
2007 |
2007 |
Arsenic Poisoning, Inorganic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Acute Myeloid Leukemia, M1
|
disease |
Neoplasms
|
Neoplastic Process
|
138
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Nervous System, Organic Arsenic Poisoning
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
450
|
128
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Arsenic Encephalopathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Arsenic Induced Polyneuropathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Positive
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
131
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Juvenile-Onset Still Disease
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
171
|
41
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
131
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Arsenic Poisoning
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
64
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Juvenile psoriatic arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
138
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Calcification of coronary artery
|
phenotype |
Nutritional and Metabolic Diseases; Cardiovascular Diseases
|
Pathologic Function
|
51
|
205
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Glycine measurement
|
phenotype |
|
Laboratory Procedure
|
32
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
3
|
2012 |
2012 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.070 |
None |
0.857 |
7 |
|
2007 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.060 |
None |
1.000 |
6 |
|
2007 |
2017 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2016 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2016 |
Gestational Diabetes
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
649
|
224
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |